Table 1.
Selected parameters of antioxidative and prooxidative factors in the study and reference group
| Parameter | Sex | Study group | Reference group | P-value | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | Min.-max. | (x) | SD | Me | N | Min.-max. | (x) | SD | Me | |||
| PON-1 [µmol/ml] | W | 31 | 17.2–61.4 | 33.1 | 9.4 | 31.4 | 16 | 40.1–91.3 | 69.2 | 17.2 | 71.8 | < 0.001 |
| M | 35 | 16.2–55.4 | 33.8 | 11 | 35.4 | 14 | 39.9–90.2 | 67.4 | 15 | 69.5 | < 0.001 | |
| All | 66 | 16.2–61.4 | 33 | 10.2 | 32.1 | 30 | 39.9–91.3 | 68.3 | 6 | 70.4 | < 0.001 | |
| α-Tocopherol [ng/ml] | W | 31 | 13.5–44.8 | 25.7 | 9.1 | 23.2 | 16 | 11.1–40.9 | 27.4 | 8.9 | 29.5 | > 0.05 |
| M | 35 | 10.2–40.1 | 21 | 8.2 | 20.8 | 14 | 12.1–44.2 | 27.2 | 9.8 | 27.4 | < 0.05 | |
| All | 66 | 10.2–44.8 | 23.2 | 8.9 | 21.5 | 30 | 11.1–44.2 | 27.3 | 9.2 | 28.2 | < 0.05 | |
| Homocysteine [µmol/l] | W | 31 | 15.3–46.9 | 25.4 | 7.9 | 22.4 | 16 | 8.2–20.1 | 12.8 | 3.4 | 12.3 | < 0.001 |
| M | 35 | 19.1–50.1 | 34.7 | 8.6 | 37.8 | 14 | 9.8–17.9 | 14.2 | 2.5 | 16.1 | < 0.001 | |
| All | 66 | 15.3–50.1 | 30.3 | 9.4 | 29.9 | 30 | 8.2–20.1 | 13.5 | 3.1 | 13.7 | < 0.001 | |
| Uric acid [mg/dl] | W | 31 | 3.6–8.1 | 5.5 | 1.1 | 5.4 | 16 | 3–6.82 | 4.9 | 1 | 5 | 0.057 |
| M | 35 | 4.6–11.2 | 6.7 | 1.3 | 6.3 | 14 | 4.6–7.9 | 6 | 0.93 | 6.1 | > 0.05 | |
| All | 66 | 3.6–11.2 | 6.1 | 1.33 | 6 | 30 | 3.01–7.9 | 5.4 | 1.13 | 5.4 | < 0.05 | |
N – number of people, W – women, M – men, x– – medium, SD – standard deviation, Me – median, PON-1 – paraoxonase-1.